Nervorum
Revolutionizing neurotechnology, step by step.
Revolutionizing neurotechnology, step by step.
Revolutionising Neurotechnology step by step.
We have conducted early-stage research of novel compounds targeting pathways for therapeutic use in Parkinson's and attention-deficit disorders.
Our goal is to map cognition outside the bounds of normative behavior, emphasizing an ethical approach, cognitive modulation and using new-generation techniques to contribute further to the understanding of neural architectures.
Responsible cognitive exploration
New-generation techniques
Neural architecture mapping
"When others stall in the dark, we build."
NOCTE INCERTA, VIA CERTA
Nervorum LLC © 2025
Discoveries at the intersection of cognition, design, and therapeutic innovation
Pharmacology Patent
Patent claims for novel compounds targeting therapeutic use in Parkinson's disease
Stage: Legal Process
Pharmacology
Discovery of a novel stimulant class with a new set of profiles and pharmacokinetic mechanisms.
Stage: Architectural Understanding
Pharmacology
Patent claims for prodrug targeting therapeutic use in attention-deficit/hyperactivity disorders.
Stage: Synthesis path discovery
"To Invent, is to unlearn"
Advancing understanding through innovative exploration
Mapping cognition outside the bounds of normative behavior.
Investigating cognitive responses to entropy, establishing a relationship between thermodynamics and attention.
"Emphasizing an ethical approach, using new-generation techniques in cognitive modulation."